levofloxacin has been researched along with polymyxin b(1) in 2 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (polymyxin b(1)) | Trials (polymyxin b(1)) | Recent Studies (post-2010) (polymyxin b(1)) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 40 | 0 | 37 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
| Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
2 other study(ies) available for levofloxacin and polymyxin b(1)
| Article | Year |
|---|---|
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |